Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction

被引:35
作者
Galve, E
Mallol, A
Catalan, R
Palet, J
Méndez, S
Nieto, E
Diaz, A
Soler-Soler, J
机构
[1] Hosp Gen Hosp Hebron, Serv Cardiol, Barcelona 08035, Spain
[2] Hosp Gen Univ Hebron, Serv Bioquim, Barcelona, Spain
关键词
heart failure; diuretics; neurohumoral activation;
D O I
10.1016/j.ejheart.2004.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Loop diuretics are beneficial in heart failure in the short term because they eliminate fluid retention, but in the long-term, they could adversely influence prognosis due to activation of neurohumoral mechanisms. Aims: To explore the changes induced by diuretic withdrawal in chronic nonadvanced heart failure. Methods: Diuretics were withdrawn in 26 stabilized heart failure patients with systolic dysfunction (ejection fraction [EF]< 45%). Clinical status was evaluated by physical exam, exercise capacity (corridor test) and New York Heart Association (NYHA) class. Biochemical and neurohumoral determinations were performed at baseline and at 3 months. Results: At 3 months, 17 out of 26 patients (65%) were able to tolerate diuretic interruption without a deterioration in exercise capacity or New York Heart Association functional class. Renal function parameters improved (baseline urea 46.2 +/- 10.8 to 39.2 +/- 10.1 mg/dl at 3 months, p=0.014; creatinine 1.1 +/- 0.23 to 0.98 +/- 0.2 mg/dl, p=0.013). Glucose metabolism also improved (fasting glucose 151 91 to 122 +/- 14 mg/dl, p=0.035). Heart rate and systolic blood pressure did not significantly change, while diastolic blood pressure increased (from 80 +/- 10 to 87 +/- 13 mm Hg, p=0.006). Neurohumoral determinations showed a decrease in plasma renin activity (4.19 +/- 5.96 to 2.88 +/- 4.98 ng/ml, p=0.026), with no changes in aldosterone, arginine-vasopressin, endothelin-1 and norepinephrine. In contrast, atrial natriuretic peptide significantly increased (115 +/- 87 to 168 +/- 155 pg/ml, p=0.004). Conclusion: Diuretic withdrawal in stabilized heart failure with systolic dysfunction is associated with an improvement in renal function parameters, glucose metabolism and some neurohumoral parameters, such as plasma renin activity; however, atrial natriuretic peptide levels increased. (c) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:892 / 898
页数:7
相关论文
共 50 条
  • [21] Decreased survival in diabetic patients with heart failure due to systolic dysfunction
    Kamalesh, M
    Subramanian, U
    Sawada, S
    Eckert, G
    Temkit, M
    Tierney, W
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (04) : 404 - 408
  • [22] Is diuretic withdrawal safe in patients with heart failure and reduced ejection fraction? A retrospective analysis of our outpatient cohort
    Romano, Giuseppe
    Vitale, Giuseppe
    Bellavia, Diego
    Agnese, Valentina
    Clemenza, Francesco
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 42 : E11 - E13
  • [23] Effects of Triamterene in Hospitalized Patients with Heart Failure and Diuretic Resistance: A Randomized Clinical Trial
    Taban-Sadeghi, Mohammadreza
    Khani, Elnaz
    Khezripour, Kimia
    Enamzadeh, Elgar
    Safaei, Naser
    Entezari-Maleki, Taher
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (12) : 1352 - 1358
  • [24] Flexible Diuretic Titration in Chronic Heart Failure: Where Is the Evidence?
    Piano, Mariann R.
    Prasun, Marilyn A.
    Stamos, Thomas
    Groo, Vicki
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (11) : 944 - 954
  • [25] The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction
    Lipinski, MJ
    Vetrovec, GW
    Gorelik, D
    Froelicher, VF
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (08) : 624 - 630
  • [26] Clinical Significance of Endogenous Vasoactive Neurohormones in Chronic Systolic Heart Failure
    Tang, W. H. Wilson
    Shrestha, Kevin
    Martin, Maureen G.
    Borowski, Allen G.
    Jasper, Sue
    Yandle, Timothy G.
    Richards, A. Mark
    Klein, Allan L.
    Troughton, Richard W.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : 635 - 640
  • [27] Diuretic resistance in patients with heart failure: Clinical characteristics and predictors of outcome
    Tasew, Mesfin
    Aklilu, Tamirat Moges
    Abdissa, Senbeta Guteta
    JOURNAL OF CLINICAL SCIENCES, 2020, 17 (03) : 66 - 73
  • [28] Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure
    Bonfils, Peter K.
    Damgaard, Morten
    Taskiran, Mustafa
    Goetze, Jens Peter
    Norsk, Peter
    Gadsboll, Niels
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (09) : 995 - 1001
  • [29] Inflammation and endothelial dysfunction in patients with chronic heart failure
    Greig, Douglas
    Castro, Pablo
    Gabrielli, Luigi
    Miranda, Rodrigo
    Verdejo, Hugo
    Alcaino, Hernan
    Bustos, Carlos
    Chiong, Mario
    Godoy, Ivan
    Mellado, Rosemarie
    Garcia, Lorena
    Salas, Daniela
    Vivar, Raul
    Vukasovic, Jose Luis
    Concepcion, Roberto
    Diaz-Araya, Guillermo
    REVISTA MEDICA DE CHILE, 2008, 136 (06) : 687 - 693
  • [30] Bone marrow dysfunction in chronic heart failure patients
    Westenbrink, B. Daan
    Voors, Adriaan A.
    de Boer, Rudolf A.
    Schuringa, Jan J.
    Klinkenberg, Theo
    van der Harst, Pim
    Vellenga, Edo
    van Veldhuisen, Dirk J.
    van Gilst, Wiek H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (07) : 676 - 684